Patients with Complete Paralysis Show Additional Recovery of Arm, Hand and Finger Function at 9-months After Treatment with Asterias’ AST-OPC1

Posted byclientekdevPosted instem cell research

http://www.prnewswire.com/news-releases/patients-with-complete-paralysis-show-additional-recovery-of-arm-hand-and-finger-function-at-9-months-after-treatment-with-asterias-ast-opc1-300472759.html

FREMONT, Calif., June 13, 2017 /PRNewswire/ — Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company pioneering the field of regenerative medicine, today announced that new 9-month follow-up data from the AIS-A 10 million cell cohort in the company’s ongoing SCiStar Phase 1/2a clinical trial shows three of six (50%) patients..